Business
Easton Pharmaceuticals and Partner BMV Medica Sign First Sales & Marketing Agreement with European Based, Multi-National Pharmaceutical Company, Gedeon Richter, For Women's Health, Sales & Marketing of its Gynofit -- Lactic Acid Gel Treatment of B
Easton Pharmaceuticals and Partner BMV Medica Sign First Sales & Marketing Agreement with European Based, Multi-National Pharmaceutical Company, Gedeon Richter, For Women's Health, Sales & Marketing of its Gynofit -- Lactic Acid Gel Treatment of B.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\n \n \n Easton Pharmaceuticals and Partner BMV Medica Sign First Sales & Marketing Agreement with European Based, Multi-National Pharmaceutical Company, Gedeon Richter, For Women's Health, Sales & Marketing of its Gynofit -- Lactic Acid Gel Treatment of Bacterial Vaginosis (BV)\n \n \nEaston Pharmaceuticals and Partner BMV Medica Sign First Sales & Marketing Agreement with European Based, Multi-National Pharmaceutical Company, Gedeon Richter, For Women's Health, Sales & Marketing of its Gynofit -- Lactic Acid Gel Treatment of Bacterial Vaginosis (BV)\n\nMarketing and Sales To Commence In February of 2017. Negotiations Continue For Other Products (VS-Sense, AL-Sense) and Territories With Multi-National Pharmaceutical Companies\n\n \n TORONTO, ON--(Marketwired - Dec 14, 2016) - Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) is pleased to announce that its partner BMV Medica SA de C.V. through its host company Ackerman Pharma, has signed a Sales & Marketing Agreement with Gedeon Richter Mexico S.A.P.I. de C.V. a Mexican-based company and affiliate of Gedeon Richter Plc, for Easton / BMV's \"Gynofit\" Lactic Acid Gel for the treatment of Bacterial Vaginosis in Mexico. http://www.richter.hu/en-US/Pages/default.aspx\n The sales and marketing agreement is for the country of Mexico, a pharmaceutical market representing almost 40% of Latin America, possessing double-digit annual growth rates. Marketing and Sales of \"Gynofit\" are expected to commence In February of 2017. \"This Agreement is instrumental for Easton / BMV's Latin American growth plans.\" Mr. Evan Karras, CEO of Easton Pharmaceuticals stated. Mr. Karras further commented, \"This represents a strong strategic relationship for Easton / BMV as Gedeon Richter Plc and its affiliate company, Mexico S.A.P.I de C.V. is a premier international pharmaceutical company focused on Women's Health, with a presence in more than 38 countries with 5 manufacturing facilities, 29 representative offices, 38 commercial subsidiaries and wholesale companies employing approximately 1000 people. This agreement adds to our previous distribution agreement announcement for Central America and the Dominican Republic for our exclusive Women's Heath line of products. We will continue to increase our distribution channels and sales opportunities in other territories for Gynofit an...